We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regulators Assess Risks of Increasing Use of AI
The International Coalition of Medicines Regulatory Authorities (ICMRA) urged regulators to consider taking a risk-based approach to the use of artificial intelligence (AI) in the pharmaceutical industry in a new report.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor